PHK
PCRX icon

Point72 Hong Kong’s Pacira BioSciences PCRX Stock Holding History

Point72 Hong Kong’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-200
Closed -$3.77K – 604
2024
Q4 		$3.77K Buy
+200
New +$3.51K ﹤0.01% 370
2022
Q3 		– Sell
-788
Closed -$46K – 2298
2022
Q2 		$46K Sell
788
-2,706
-77% -$177K ﹤0.01% 1385
2022
Q1 		$267K Buy
3,494
+1,746
+100% +$116K 0.01% 876
2021
Q4 		$105K Buy
1,748
+1,656
+1,800% +$91.3K ﹤0.01% 1164
2021
Q3 		$5K Sell
92
-6,530
-99% -$376K ﹤0.01% 1843
2021
Q2 		$402K Buy
+6,622
New +$419K 0.01% 979
2021
Q1 		– Sell
-847
Closed -$51K – 2111
2020
Q4 		$51K Buy
+847
New +$49.6K ﹤0.01% 1215
2020
Q3 		– Sell
-2,706
Closed -$142K – 1438
2020
Q2 		$142K Buy
+2,706
New +$113K 0.02% 566
2019
Q4 		– Sell
-1,239
Closed -$47K – 1386
2019
Q3 		$47K Buy
1,239
+735
+146% +$29.3K 0.01% 591
2019
Q2 		$22K Buy
504
+493
+4,482% +$20.9K 0.01% 764
2019
Q1 		$0 Buy
+11
New +$429 ﹤0.01% 1217
2018
Q3 		– Sell
-90
Closed -$3K – 1111
2018
Q2 		$3K Sell
90
-231
-72% -$7.97K ﹤0.01% 752
2018
Q1 		$10K Sell
321
-1
-0.3% -$36 0.01% 694
2017
Q4 		$15K Buy
322
+212
+193% +$8.4K 0.01% 428
2017
Q3 		$4K Buy
110
+89
+424% +$3.58K ﹤0.01% 594
2017
Q2 		$1K Sell
21
-910
-98% -$42.2K ﹤0.01% 726
2017
Q1 		$42K Buy
+931
New +$40.2K 0.05% 273

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Point72 Hong Kong's PCRX Position: Q1 2025 in Review

Point72 Hong Kong sold out of Pacira BioSciences (PCRX) in Q1 2025, closing a stake of 200 shares — an estimated $3.77K sold.

Point72 Hong Kong first reported a position in PCRX in Q1 2017 and held it in 17 quarters. The position peaked at $402K in Q2 2021. 235 funds tracked by Wall St. Rank hold PCRX as of Q1 2025.

  • Point72 Hong Kong reported no remaining Pacira BioSciences position as of Q1 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 200 Pacira BioSciences shares in Q1 2025, an estimated $3.77K.
  • Point72 Hong Kong first reported a position in Pacira BioSciences in Q1 2017 and held it in 17 quarters.
  • Point72 Hong Kong's Pacira BioSciences position peaked at $402K in Q2 2021.
  • 235 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2025.

Based on Point72 Hong Kong's 13F filing for Q1 2025, filed 15 May 2025.